6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: November 30, 2011
Period of Report: November 30, 2011
Accession Number: 0001144204-11-067613

View Document ↗ View on SEC.gov ↗